3-Acetyl-5-butyldihydro-2(3H)-furanone
Common Name: |
3-Acetyl-5-butyldihydro-2(3H)-furanone |
IUPAC Name: |
(3R,5S)-3-acetyl-5-butyloxolan-2-one |
Molecular Formula: |
C15H20O3 |
SMILES: |
CCCCC1CC(C(=O)O1)C(=O)C |
Inchi: |
1S/C10H16O3/c1-3-4-5-8-6-9(7(2)11)10(12)13-8/h8-9H,3-6H2,1-2H3/t8-,9+/m0/s1 |
Inchi Key: |
NEBMUHXPHLFPGQ-DTWKUNHWSA-N |
Cas No: |
40010-99-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
248.32 |
Mass (g/mol) |
184.11 |
Molar Refractivity |
72.96 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
7 |
Rings |
1 |
TPSA |
35.53 |
Hetero Atoms |
3 |
Heavy Atoms |
18 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
122.00 @ 0.50 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.000332 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.40 |
LogP |
1.697 |
iLOGP |
3.35 |
XLOGP3 |
3.57 |
WLOGP |
3.38 |
MLOGP |
3.22 |
ESOL Log S |
-3.41 |
ESOL Solubility (mg/ml) |
0.096 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.00 |
Ali Solubility (mg/ml) |
0.02 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-4.30 |
Silicos-IT Solubility (mg/ml) |
0.01 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.28 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.783 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.545 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |